Trifluorothymidine en es it fr

Trifluorothymidine Brand names, Trifluorothymidine Analogs

Trifluorothymidine Brand Names Mixture

  • No information avaliable

Trifluorothymidine Chemical_Formula


Trifluorothymidine RX_link

Trifluorothymidine fda sheet

Trifluorothymidine FDA

Trifluorothymidine msds (material safety sheet)

Trifluorothymidine Synthesis Reference

No information avaliable

Trifluorothymidine Molecular Weight

718.794 g/mol

Trifluorothymidine Melting Point

No information avaliable

Trifluorothymidine H2O Solubility

No information avaliable

Trifluorothymidine State


Trifluorothymidine LogP


Trifluorothymidine Dosage Forms

Powder for solution to be mixed for injection (2mg verteporfin/mL reconstituted verteporfin)

Trifluorothymidine Indication

For the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis.

Trifluorothymidine Pharmacology

Verteporfin, otherwise known as benzoporphyrin derivative, is a medication used in conjunction with laser treatment to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. Verteporfin accumulates in these abnormal blood vessels and, when stimulated by nonthermal red light with a wavelength of 693 nm in the presence of oxygen, produces highly reactive short-lived singlet oxygen and other reactive oxygen radicals, resulting in local damage to the endothelium and blockage of the vessels.

Trifluorothymidine Absorption

No information avaliable

Trifluorothymidine side effects and Toxicity

Overdose of drug and/or light in the treated eye may result in nonperfusion of normal retinal vessels with the possibility of severe decrease in vision that could be permanent. An overdose of drug will also result in the prolongation of the period during which the patient remains photosensitive to bright light.

Trifluorothymidine Patient Information

Trifluorothymidine Organisms Affected

Humans and other mammals